Trial Profile
Comparison of two everolimus-eluting stents in an all-comers population
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Dec 2011
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 01 Dec 2011 New trial record
- 11 Nov 2011 Preliminary results presented at the 23rd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.